Director of Clinical Service Provider Contracting

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Opportunity: 

The Director of Clinical Service Provider Contracting, Early Stage, will lead Service Provider sourcing, requests for information/proposal (RFIs/RFPs), contracting, and governance for assigned early-stage clinical programs.

This role will partner with Clinical Operations and study teams to define service requirements and establish agreements that support first-in-human, dose-escalation, and dose-expansion studies. The Director will manage contracting priorities, negotiate commercial terms, and oversee Service Provider relationships in collaboration with Clinical Business Operations, Finance, Legal, Procurement, and Quality.

• Develop sourcing plans for assigned early-stage studies, aligning Service Provider selection and contracting milestones with study startup and program priorities.

• Generate RFIs, RFPs and budget grids/trackers for clinical trials. Lead RFI/RFP development with study teams, defining scope, deliverables, responsibilities, timelines, budget assumptions, and evaluation criteria.

• Coordinate proposal reviews, bid comparisons, and bid defense meetings, and assist Clinical Development Management with the Service Provider selection process. Evaluate Service Provider capabilities, early-stage oncology experience, capacity, proposed staffing, costs, and delivery risks.

• Document selection recommendations. Partner with Clinical Quality Assurance (CQA), Information Sciences (IS) and relevant functions to ensure all selected Service Providers are qualified and IS Security Assessments are conducted before engagement, according to SOPs and business processes.

• Maintain market intel (rates, KPIs), benchmark proposed rates against market data, and recommend sourcing approaches.

Contract negotiation and execution

• Lead commercial negotiations for Service Provider master service agreements, statements of work, work orders, change orders, and consulting agreements, partnering with Legal on contractual terms and risk.